| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 01/19/2012 | US20120014959 Wise/sost nucleic acid sequences and amino acid sequences |
| 01/19/2012 | US20120014952 Complement receptor 2 targeted complement modulators |
| 01/19/2012 | US20120014948 Genetic products differentially expressed in tumors and use thereof |
| 01/19/2012 | US20120014942 Method for the diagnosis and prognosis of malignant diseases |
| 01/19/2012 | US20120014905 Conugated proteins and peptides |
| 01/19/2012 | US20120014873 Peptides whose uptake by cells is controllable |
| 01/19/2012 | US20120012823 Color imaging element and method of manufacturing the same, photosensor and method of manufacturing the same, photoelectric transducer and method of manufacturing the same, and electronic device |
| 01/19/2012 | DE112009002267T5 Pflanzen mit erhöhtem Ertrag (LT) Plants having increased yield (LT) |
| 01/19/2012 | CA2805677A1 Deamidated barley proteins |
| 01/19/2012 | CA2805560A1 Protein binding domains stabilizing functional conformational states of gpcrs and uses thereof |
| 01/19/2012 | CA2805408A1 Novel nitrate reductase fusion proteins and uses thereof |
| 01/19/2012 | CA2805325A1 Insulin-lipid complex, preparation method therefor, and preparation thereof |
| 01/19/2012 | CA2805306A1 Diagnostic method for colitis |
| 01/19/2012 | CA2805300A1 Human papillomavirus e7 antigen compositions and uses thereof |
| 01/19/2012 | CA2805170A1 Gene therapy composition for use in diabetes treatment |
| 01/19/2012 | CA2804753A1 Anti-angiogenic agent and methods of using such agent |
| 01/19/2012 | CA2804121A1 Modified viral strains, and method for improving the production of vaccine seeds of the influenza virus |
| 01/19/2012 | CA2802283A1 Live attenuated parvovirus |
| 01/19/2012 | CA2802207A1 Materials and method for suppressing inflammatory and neuropathic pain |
| 01/19/2012 | CA2802126A1 Asparaginase from basidiomycetes |
| 01/18/2012 | EP2407561A2 A method for the preparation of recombinant human fibrinogen |
| 01/18/2012 | EP2407542A1 Recombinant vaccines against caligid copepods (sea lice) and antigen sequences thereof |
| 01/18/2012 | EP2407536A1 ADP-ribosyl transferase fusion variant proteins |
| 01/18/2012 | EP2407488A2 Establishment of induced pluripotent stem cell using cell-permeable reprogramming transcription factor for customized stem cell therapy |
| 01/18/2012 | EP2407484A2 Therapeutic pro-apoptotic BH3-like molecules and methods for generating and/or selecting the same |
| 01/18/2012 | EP2407483A1 Methods of treating, diagnosing or detecting cancers |
| 01/18/2012 | EP2407482A1 Lactobacillus acidophilus nucelic acid sequences encoding carbohydrate utilization-related proteins and uses therefor |
| 01/18/2012 | EP2407481A1 Lactobacillus acidophilus nucelic acid sequences encoding carbohydrate utilization-related proteins and uses therefor |
| 01/18/2012 | EP2407480A1 Materials and methods for respiratory disease control in canines |
| 01/18/2012 | EP2407477A1 Method for purifying bone morphogenetic protein |
| 01/18/2012 | EP2407177A1 Adenovirus vaccine vectors |
| 01/18/2012 | EP2407175A1 Agents with angiogenic and wound healing activity |
| 01/18/2012 | EP2407172A1 Peptide sequences and compositions |
| 01/18/2012 | EP2406636A2 Methods of diagnosing and predicting renal disease |
| 01/18/2012 | EP2406627A2 A pkn3/rhoc macromolecular complex and methods of use therefor |
| 01/18/2012 | EP2406399A1 Mirac proteins |
| 01/18/2012 | EP2406395A1 Diagnosis and treatment of cell proliferation and differentiation disorders based on the fmn2 gene |
| 01/18/2012 | EP2406377A2 A polynucleotide and polypeptide sequence and methods thereof |
| 01/18/2012 | EP2406286A2 Anti-cd40 antibodies and uses thereof |
| 01/18/2012 | EP2406282A1 Interleukin-21 variants having antagonistic binding to the il-21 receptor |
| 01/18/2012 | EP2406281A2 Bone morphogenetic protein 2 (bmp2) variants with reduced bmp antagonist sensitivity |
| 01/18/2012 | EP2406280A1 Biological materials and uses thereof |
| 01/18/2012 | EP2406279A2 Compositions and methods for prevention and treatment of neurodegenerative diseases |
| 01/18/2012 | EP2406278A2 Axmi-001, axmi-002, axmi-030, axmi-035, and axmi-045: insecticidal proteins from bacillus thuringiensis and methods for their use |
| 01/18/2012 | EP2406277A1 New strain of salmonella enterica s. typhimurium, its use and a method to obtain a therapeutic vaccine vector |
| 01/18/2012 | EP2406276A1 Methods of renaturation of recombinant proteins |
| 01/18/2012 | EP2405939A1 Optimized early-late promoter combined with repeated vaccination favors cytotoxic t cell response against antigens in replication deficient recombinant virus vaccines |
| 01/18/2012 | EP2405938A2 Nontypable haemophilus influenzae antigens |
| 01/18/2012 | EP2405936A1 Injectable biomaterials |
| 01/18/2012 | EP2405932A2 Sparc angiogenic domain and methods of use |
| 01/18/2012 | EP2405921A1 Compositions and methods for silencing apolipoprotein c-iii expression |
| 01/18/2012 | EP2271665B1 Highly bridged peptides from actinomadura namibiensis |
| 01/18/2012 | EP2201377B1 Purinergic (p2x) receptors in extra-cellular body fluid |
| 01/18/2012 | EP1928915B1 An ultra-high yield intravenous immune globulin preparation |
| 01/18/2012 | EP1799868B1 Hcv non-structural protein mutants and uses thereof |
| 01/18/2012 | EP1743940B1 Cardioinhibitory/ antihypertensive novel endogenous physiologically active peptide |
| 01/18/2012 | EP1726310B1 Drug for cancer therapy |
| 01/18/2012 | EP1704234B1 Production of glucagon like peptide 2 and analogs |
| 01/18/2012 | EP1696945B1 Self-assembling peptide amphiphiles and related methods for growth factor delivery |
| 01/18/2012 | EP1659858B1 Transgenic mice having a human major histocompatibility complex (mhc) phenotype, experimental uses and applications |
| 01/18/2012 | EP1456385B1 Growth hormone fusion protein |
| 01/18/2012 | EP1454138B1 Immunocytokines with modulated selectivity |
| 01/18/2012 | EP1440092B1 Photoactivatable composition and the use of same |
| 01/18/2012 | EP1390075B1 Chemotherapeutic induction of egr-1 promoter activity in gene therapy |
| 01/18/2012 | EP1292709B1 Conjugate addition reactions for the controlled delivery of pharmaceutically active compounds |
| 01/18/2012 | EP1257822B1 Her-2 binding antagonists |
| 01/18/2012 | EP1123388B1 Transgenic c. elegans as a model organism for research into alzheimer's disease |
| 01/18/2012 | CN102325885A Methods and compositions for diagnosis and treatment of cancer |
| 01/18/2012 | CN102325884A Hypo-immunogenic streptavidin and use thereof |
| 01/18/2012 | CN102325882A Protein substance having triple helix structure and manufacturing method therefor |
| 01/18/2012 | CN102325792A Means and methods for manufacturing highly pure neurotoxin |
| 01/18/2012 | CN102325791A Modular DNA-binding domains and methods of use |
| 01/18/2012 | CN102325790A Use of phenol-soluble modulins for vaccine development |
| 01/18/2012 | CN102325789A Visfatin therapeutic agents for treatment of acne and other conditions |
| 01/18/2012 | CN102325542A Compositions and methods to prevent cancer with cupredoxins |
| 01/18/2012 | CN102325442A Engineering heat-stable disease resistance in plants |
| 01/18/2012 | CN102321658A Mutation method of recombinant protein of pig somatic cells |
| 01/18/2012 | CN102321636A Protein for gene recombinant prokaryotic expression of duck plague virus gG as well as preparation method and application thereof |
| 01/18/2012 | CN102321634A Preparation method of mink enteritis parvovirus empty capsid antigen particles |
| 01/18/2012 | CN102321633A Pleiotropic gene for controlling vegetative growth and development of floral organs of rice and application thereof |
| 01/18/2012 | CN102321630A Preparation method of core fragment rIFN (interferon)-alpha1of recombinant chicken IFN-alpha |
| 01/18/2012 | CN102321629A Method for preparing gelsolin from Dendrorhynchus zhejiangensis |
| 01/18/2012 | CN102321628A C-type agglutinin gene of procambarus clarkia as well as preparation method and applications thereof |
| 01/18/2012 | CN102321602A Applications of beta-lactamase in improving functional protein folding and preparation of fusion protein |
| 01/18/2012 | CN102321590A Preparation method of asymmetric virus nanoparticles |
| 01/18/2012 | CN102321547A Recombination yeast engineering bacteria expressing reticuloendotheliosis virus (REV) Gp90 protein, its construction method and application |
| 01/18/2012 | CN102321184A Resource utilization technology of fresh peltate yam |
| 01/18/2012 | CN102321171A Synthetic method of artificial antigen suitable for alkylphenol medicament |
| 01/18/2012 | CN102321170A Liraglutide variant and conjugate thereof |
| 01/18/2012 | CN102321169A Canine recombinant interferon alpha and preparation method |
| 01/18/2012 | CN102321168A Method for renaturing and purifying novel thrombopoietin |
| 01/18/2012 | CN102321167A Antigen epitope peptide of alpha fetoprotein, nucleic acid, preparation method of nucleic acid, recombinant vector, host cell, hybridoma cell, monoclonal antibody and kit |
| 01/18/2012 | CN102321166A Method for separating phosphatide binding protein from duck muscles |
| 01/18/2012 | CN102321165A Hainantoxin-XXI and application of hainantoxin-XXI in preparing analgesic and anti-inflammatory drugs and in preparing reagent for studying TRPV1 channel |
| 01/18/2012 | CN102321164A Preparation method and application of insect natural antibacterial peptide products |
| 01/18/2012 | CN102321163A Sea island cotton lipid transfer protein and application in fiber improvement thereof |
| 01/18/2012 | CN102321162A GbRPS1 gene for resisting plant fusarium wilt and verticillium wilt and application thereof |
| 01/18/2012 | CN102321161A Short peptide capable of improving expression of protein in plant cell and application thereof |
| 01/18/2012 | CN102321160A Production technology of sesame protein powder |
| 01/18/2012 | CN102319429A Peptide-based passive immunization therapy for treatment of atherosclerosis |